Psoriasis is a chronic disease affecting over 125 million people all over the world and an increasing trend has been observed [1,2]. As a systemic inflammatory process, it predisposes, twice as frequently than in the general population, to the development of metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardio-vascular diseases) and, consequently, to life shortening.Stem Cells in the Tx of Psoriasis Oct 2017
Inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis are considered major public issues with increasing prevalence due to the rapid industrialization of modern society. These diseases are more frequent in industrialized countries than in developing countries with higher prevalence in urban areas compared to rural areas.MSC's in Inflammatory Skin Diseases Feb 2017
Chronic wounds represent a growing healthcare burden that particularly afflicts aged, diabetic, vasculopathic, and obese patients.BMAC in Skin Tissue Regeneration April 2017
Three-week topical treatment with placenta – derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer
The International Diabetes Federation reported that, at present, there are 415 million subjects worldwide with diabetes mellitus (DM) aged between 20 and 79 years, with a global prevalence of 8.8%, which by 2030 will increase to >360 million.MSC's (topical) in the Tx of Diabetic Foot Ulcer Dec 2017
The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia , and Non-healing Wounds)
Brown and white adipose tissue is a source of mesenchymal stem cells, specifically adipose-derived stem cells (ADSCs). It is an inexpensive, unlimited reservoir of stem cells. From
300 ml of adipose tissue, 2-3 × 108 ADSCs can be obtained.